Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ireland

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Acta Chirurgica Scandinavica. Supplementum|January 1, 1988
Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failureD A Lane, H Ireland, C J Tew, et al.
Journal of Hepatology|January 5, 2005
Transient segmental liver ischaemia after polytetrafluoroethylene transjugular intrahepatic portosystemic stent-shunt procedureJ W Ferguson, D Tripathi, D N Redhead, et al.
British Journal of Haematology|April 1, 1983
Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptideD A Lane, C Southan, H Ireland, et al.
Thrombosis and Haemostasis|April 8, 1988
Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222H Ireland, D A Lane, A Flynn, et al.
British Journal of Haematology|September 1, 1996
Prenatal diagnosis in combined antithrombin and factor V gene mutationD A Lane, K Auberger, H Ireland, et al.
British Journal of Haematology|November 1, 1988
Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222C J Tew, D A Lane, E Thompson, et al.
British Journal of Haematology|August 1, 1987
Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosisD A Lane, G D Lowe, A Flynn, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Haemodialysis with prostacyclin (Epoprostenol) aloneP B Rylance, M P Gordge, H Ireland, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 6, 2000
The thrombomodulin gene mutation G(127)-->A (Ala25Thr) and cerebrovascular diseaseD Warner, A Catto, G Kunz, et al.
Human Molecular Genetics|November 1, 1994
A polymorphism in the human coagulation factor V geneT A Bayston, H Ireland, R J Olds, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Acta Chirurgica Scandinavica. Supplementum|January 1, 1988
Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failureD A Lane, H Ireland, C J Tew, et al.
Journal of Hepatology|January 5, 2005
Transient segmental liver ischaemia after polytetrafluoroethylene transjugular intrahepatic portosystemic stent-shunt procedureJ W Ferguson, D Tripathi, D N Redhead, et al.
British Journal of Haematology|April 1, 1983
Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptideD A Lane, C Southan, H Ireland, et al.
Thrombosis and Haemostasis|April 8, 1988
Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222H Ireland, D A Lane, A Flynn, et al.
British Journal of Haematology|September 1, 1996
Prenatal diagnosis in combined antithrombin and factor V gene mutationD A Lane, K Auberger, H Ireland, et al.
British Journal of Haematology|November 1, 1988
Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222C J Tew, D A Lane, E Thompson, et al.
British Journal of Haematology|August 1, 1987
Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosisD A Lane, G D Lowe, A Flynn, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Haemodialysis with prostacyclin (Epoprostenol) aloneP B Rylance, M P Gordge, H Ireland, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 6, 2000
The thrombomodulin gene mutation G(127)-->A (Ala25Thr) and cerebrovascular diseaseD Warner, A Catto, G Kunz, et al.
Human Molecular Genetics|November 1, 1994
A polymorphism in the human coagulation factor V geneT A Bayston, H Ireland, R J Olds, et al.
Pageof 15